Autolus Therapeutics PLC
(NASDAQ:AUTL)
$2.07
At close: Feb 2
$2.17
0.1000[4.83%]
PreMarket: 4:53PM EDT
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Autolus Therapeutics Stock (NASDAQ:AUTL), Quotes and News Summary

Autolus Therapeutics Stock (NASDAQ: AUTL) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range1.600 - 5.040Open / Close- / -Float / Outstanding- / 173.059M
Vol / Avg.0 / 627.863KMkt Cap358.233MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float-EPS-1.850
Globe Newswire - Jan 20, 2023, 7:00AM
Globe Newswire - Dec 8, 2022, 9:11PM
TipRanks - Oct 12, 2022, 9:35AM
Seeking Alpha - Oct 5, 2022, 11:43PM
Sector: Health Care.Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-03-09
REV
Q3 2022Est.ActualSurprise
EPS-0.470
REV2.369M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ: AUTL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Autolus Therapeutics's (AUTL) competitors?

Q

What is the target price for Autolus Therapeutics (AUTL) stock?

A

The latest price target for Autolus Therapeutics (NASDAQ: AUTL) was reported by Needham on Friday, December 9, 2022. The analyst firm set a price target for 7.00 expecting AUTL to rise to within 12 months (a possible 238.16% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $2.07 last updated February 2, 2023 at 9:00 PM UTC.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics’s Q4 earnings are confirmed for Thursday, March 9, 2023.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.